#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Undifferentiated sarcoma Fibrosarcoma metastatic Metachromatic leukodystrophy Astrocytoma malignant Non-small cell lung cancer metastatic Severe myoclonic epilepsy of infancy Enteritis Gastroenteropancreatic neuroendocrine tumour disease Urethral valves Thalassaemia alpha Anal cancer recurrent Obesity Cutaneous T-cell lymphoma Cutaneous lupus erythematosus Rectal cancer More trials…

    Learn about Rare Diseases

    MELAS syndrome – Basic Information Fabry’s disease Undifferentiated sarcoma – Treatment Hereditary hypophosphataemic rickets – Treatment Hereditary neuropathic amyloidosis Familial haemophagocytic lymphohistiocytosis – Trials in Disease Progressive supranuclear palsy – Diagnostics Small intestine leiomyosarcoma – Diagnostics Bronchiolitis obliterans syndrome – Treatment Encephalitis autoimmune – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    NAVENIBART Fluticasone Alnus Glutinosa Pollen Paroxetine Hydrochloride Gfh925 ALLERGEN EXTRACTS Cholic Acid Apixaban Ganaxolone Benralizumab Sodium Acetate (1-13C) Ep0031 Bgb-A445 Oms906 FOSFOMYCIN CALCIUM Albumin Vinorelbine Pegipanermin LUTETIUM LU-177 Clic-1901 Cart More therapies…

    Learn about Your Condition

    Pituitary tumour benign Ventricular fibrillation Pancreatitis chronic Anal incontinence Carcinoid tumour pulmonary Hepatocellular carcinoma Metastases to liver Death neonatal Hypotransferrinaemia IgA nephropathy Primary hyperoxaluria Laryngeal leukoplakia Microvillous inclusion disease Fatty acid oxidation disorder Fabry's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Agaplesion Evangelisches Krankenhaus Mittelhessen gGmbH…

Agaplesion Evangelisches Krankenhaus Mittelhessen gGmbH

Paul-Zipp-Strasse 171, Giessen, 35398, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    • Depemokimab
    Austria Bulgaria Czechia Germany Greece Italy +2
  • Study of inhaled LTI-03 for safety and effectiveness in patients with Idiopathic Pulmonary Fibrosis who may be receiving standard antifibrotic therapy

    Recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • LTI-03
    Germany Poland
  • Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • TALADEGIB
    Austria Belgium France Germany Ireland Italy

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!